The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 1, 2002, Pages 9-14

  Finizia, Caterina ^a   Lundell, Lars ^a   Cange, Lars ^a   Ruth, Magnus ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

24 h pH metry; Gastro oesophageal reflux; Lower oesophageal sphincter; Manometry; Peristalsis; Transient sphincter relaxation

Indexed keywords

CISAPRIDE; DOMPERIDONE; METOCLOPRAMIDE; MOSAPRIDE CITRATE; PLACEBO; SEROTONIN 4 AGONIST;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS PH; FEMALE; FUNCTIONAL ASSESSMENT; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; INTESTINE DISTENSION; LOWER ESOPHAGUS SPHINCTER; MALE; MOTOR ACTIVITY; NAUSEA; PATHOGENESIS; PERISTALSIS; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEVE MANOMETRY; STOMACH PH; SYMPTOMATOLOGY;

ADULT; AGED; CISAPRIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; MALE; MANOMETRY; MIDDLE AGED; SEROTONIN AGONISTS;

EID: 0036157585     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200201000-00003     Document Type: Article

References (37)

1. Gastric distension: A mechanism for postprandial gastroesophageal reflux
2. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux
3. The pathophysiology of gastro-oesophageal reflux disease: An overview
4. Effect of peristaltic dysfunction on esophageal volume clearance
5. Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease?
6. Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomised clinical study
7. Effect of Nissen fundoplication on esophageal motor function
8. Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease
9. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders
10. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig
11. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastro-esophageal reflux disease
12. The efficacy of a 40-mg extended-release formulation of cisapride in the treatment of patients with gastro-oesophageal reflux
13. Heartburn treatment in primary care: Randomised, double blind study for 8 weeks
14. Update on the pathophysiology and management of gastro-oesophageal reflux disease: The role of prokinetic therapy
15. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients
16. Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal esophagus in man
17. Effect of cisapride on the gastro-esophageal function in normal human subjects
18. Effects of cisapride on distal esophageal motility in humans
19. Effect of cisapride, a new prokinetic agent, on esophageal motor function
20. Cisapride stimulates human esophageal motility
21. Effect of cisapride on postprandial gastro-oesophageal reflux
22. The effect of cisapride in patients with reflux esophagitis: An ambulatory esophageal manometry/pH-metry study
23. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients
24. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease
25. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis. A study using 24 hour ambulatory pH and pressure monitoring
26. Oesophageal motor function before and after healing of oesophagitis
27. Macroscopic healing of esophagitis does not improve esophageal motility
28. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs
29. Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal
30. Salivary function in patients with reflux esophagitis: Effect of cisapride
31. Mechanisms of oesophageal mucosal defence
32. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease
33. Diabetic gastropathy: Gastric neuromuscular dysfunction in diabetes mellitus: A review of symptoms, pathophysiology, and treatment
34. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease
35. Effects of the 5-HT3 receptor antagonist, ICS 205-930, on oesophageal motor activity and on lower oesophageal sphincter pressure: A double-blind cross-over study
36. Control of transient lower esophageal sphincter relaxations and reflux by the GABAb agonist baclofen in normal subjects